Doctor Offers Vaccines to Starving Children
Conclusion
The effects of chronic malnutrition on the children and the economy of Guatemala are being turned into statistics by researchers, but common sense tells us what we already know: there will be lifelong impairments to the citizens and the collective people of this country.
Dr. Asturias’ plan may appear to be sound and noble when you read the headline in the mainstream media. However, when you consider the most pressing needs faced by the citizens of Guatemala, including lack of food, lack of clean water, and lack of education, vaccines (even if you are among the shrinking group of people who still believe ...
Source: vactruth.com - November 17, 2013 Category: Health Medicine and Bioethics Commentators Authors: Missy Fluegge Tags: Missy Fluegge Top Stories Dr. Edwin Asturias Vaccine Safety Source Type: blogs
Yet another incompetent regulator. The General Pharmaceutical Council is criminally negligent
Conclusions
The main conclusion from all of this is that the General Pharmaceutical Council is almost criminally negligent. It continues to allow pharmacists, Anthony Pinkus among them, to endanger lives. It fails to apply its own declared principles. The members of its Council, and Duncan Rudkin (its chief executive and registrar), are not doing their job.
Individual pharmacists vary a lot, from the superb to those who believe in quackery. Some, perhaps many, are embarrassed by the fact that their employer compels them to sell rubbish. It’s too much to expect that they’ll endanger their mortgage payments by sp...
Source: DC's goodscience - November 4, 2013 Category: Professors and Educators Authors: David Colquhoun Tags: Ainsworths Alliance Boots Anthony Pinkus Avogadro CAM General Chiropractic Council General Pharmaceutical Council homeopathy Royal Pharmaceutical Society Ainsworth's malaria meningitis pertussis pharmacists Pharmacy regulator Source Type: blogs
Top stories in health and medicine, October 9, 2013
From MedPage Today:
Size a Key Factor in ACO Formation. Accountable care organizations (ACOs) tend to form around larger integrated hospital systems and larger primary care physician groups, and in areas with a higher prevalence of hospital risk-sharing.
Malaria Vaccine Candidate Has Protective Effect. A candidate vaccine against malaria had significant efficacy in a randomized controlled phase III trial in Africa.
Bisphosphonates Raise Afib Risk. Bisphosphonate use was associated with significantly increased risks of atrial fibrillation and serious atrial fibrillation.
Hypothermia Has No Benefit in Meningitis. Patients ...
Source: Kevin, M.D. - Medical Weblog - October 9, 2013 Category: Family Physicians Tags: News Endocrinology Heart Infectious disease Source Type: blogs
Pharmalot... Pharmalittle... Good Morning
Hello, everyone, and how are you this morning? A strong sun and cool breeze are enveloping the leafy Pharmalot corporate campus, where we await the arrival of the grounds crew to tidy up. This may be a long wait, however. In the interim, yes, we are brewing a needed cup of stimulation - our flavor is the seasonal favorite, Pumpkin Spice - and we invite you to join us, as always. An extra kick at the start of the day is always welcome, yes? Now, though, the time has come to get cracking. So here are a few items of interest. Have a grand day...
Glaxo Seeks To Market First Malaria Vaccine (The Guardian)
The Shutdown Update On...
Source: Pharmalot - October 8, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
NIH and Other Public Private Partnerships to Research Treatments for Multiple Diseases
Over the past few weeks, the National Institutes of Health (NIH) has made a number of important announcements regarding collaborations with industry as well as the funding of several new research initiatives. Below is a summary of these stories.
NIH Partners With Eli Lilly and Others on Rare Diseases
FierceBiotechResearch reported that NIH selected four (4) new preclinical drug development studies to uncover new therapies for rare diseases. The projects will be funded through the Therapeutics for Rare and Neglected Diseases (TRND) program under NIH's National Center for Advancing Translational Sciences, NCATS, whic...
Source: Policy and Medicine - October 4, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
Pharmalot... Pharmalittle... Good Morning
Good morning, everyone, and how are you today? Once again, we are scrambling to assist the short people on their journeys to the local schoolhouses, an exercise in patience and determination. Perhaps, you can relate. In any event, another busy day is on the way. And there is no time to dilly dally. So please join us as we reach for our treasured cup of stimulation - our flavor today is the ever-seasonal Pumpkin Spice - and fire up our remaining neurons. And as always, we have some tidbits for you. Dig in and get started. And, of course, have a successful day...
Lundbeck And Takeda Win FDA OK For Depression Drug (Bloomberg ...
Source: Pharmalot - October 1, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
Twerking Disease: The Definitive Medical Resource For Doctors.
This study was published in Time magazine so it must be true. In addition, the story was picked up by 95.8 THE BONE and was described by a self proclaimed expert twerker jockey between songs about booty slappin' and G-thangs.
EXERCISE
Studies have shown most folks watching Richard Simmons in "Twerking to the Oldies" have been cured of their twerking addiction.
MIRROR THERAPY
Consider buying a full length wall mirror for full therapeutic effect. Alternatively, take a video of yourself twerking while checking yourself out in a mirror, put it on YouTube and let ever...
Source: The Happy Hospitalist - September 7, 2013 Category: Internists and Doctors of Medicine Authors: Tamer Mahrous Source Type: blogs
Inadvertent transfer of a mammalian retrovirus into birds
Reticuloendotheliosis viruses (REVs) are retroviruses that cause a rare disease of gamebirds and waterfowl that includes anemia, immunosuppression, neoplasia, runting, and abnormal feathering. Since the first isolation of REV from a turkey in 1957, REVs were believed to be strictly avian viruses. It now appears that REVs are mammalian viruses that were accidentally introduced into birds in the 1930s during research on malaria.
During an investigation of endogenous retrovirus diversity in Malagasy mammals, the authors found sequences related to REVs in the genomes of the ring-tailed mongoose and the narrow-striped mongoose....
Source: virology blog - August 27, 2013 Category: Virology Authors: Vincent Racaniello Tags: Basic virology Information bird fowlpox virus gallid herpesvirus iatrogenic reticuloendotheliosis virus viral Source Type: blogs
Inadvertent transfer of a mammalian retrovirus into birds
Reticuloendotheliosis viruses (REVs) are retroviruses that cause a rare disease of gamebirds and waterfowl that includes anemia, immunosuppression, neoplasia, runting, and abnormal feathering. Since the first isolation of REV from a turkey in 1957, REVs were believed to be strictly avian viruses. It now appears that REVs are mammalian viruses that were accidentally introduced into birds in the 1930s during research on malaria.
During an investigation of endogenous retrovirus diversity in Malagasy mammals, the authors found sequences related to REVs in the genomes of the ring-tailed mongoose and the narrow-striped mongoose....
Source: virology blog - August 27, 2013 Category: Virology Authors: Vincent Racaniello Tags: Basic virology Information bird fowlpox virus gallid herpesvirus iatrogenic reticuloendotheliosis virus viral Source Type: blogs
The Most Important Book Written This Decade
In Western Pennsylvania there is a small town by the name of Roseto.
Settled in 1912 by immigrant Italian families coming to the New World it was like a 1,000 other similar towns all over the USA.
Except that is, for one striking detail.
It was noticed in the early 1960’s that the inhabitants of Roseto had strikingly low levels of heart disease and far lower occurrences of heart attacks than surrounding communities.
We all know that not smoking, exercising regularly, drinking in moderation and eating well are amongst the keystones habits to good health, which is what made the findings so puzzling to the scientists pourin...
Source: Life Coach Blog: The Discomfort Zone : - August 18, 2013 Category: Life Coaches Authors: Tim Brownson Tags: Reviews & Previews Source Type: blogs
Pharmalot... Pharmalittle... Good Morning
Good morning, everyone, and nice to see you again. We have emerged from a long summer weekend, a treasure respite that allowed some time to catch up with life. Now, of course, another busy working week is now upon us and we look forward to a productive few days. To get started, yes, we are brewing our mandatory cup of stimulation and invite you to join us. As always, here are some tidbits to help you on your way. Have a great day and stay in touch...
Teva Gets EU Approval For Neulasta Biobetter (Pharma Times)
India Revokes Patents On Two Allergan Drugs (Economic Times)
Lupin Creates R&D Center In The US (DNA India)
Ran...
Source: Pharmalot - August 12, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
What is BUKO Pharma-Kampagne?
http://www.en.bukopharma.de/BUKO Pharma-Kampagne was founded with the aim of examining the activities of the German pharmaceutical industry in Third World countries. We want to implement changes by taking special actions and informing the public in detail. Pharma-Kampagne is a campaigning group of the Bundeskoordination Internationalismus(BUKO) (Federal Coordination of Internationalism) uniting 130 German action and solidarity groups working in favour of the Third World. More than 20 years ago, BUKO Pharma-Kampagne started to pay attention to the theme "Drugs and the Third World ". Today it is one of the fe...
Source: PharmaGossip - May 28, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
How Drug Companies Keep Medicine Out of Reach - The Atlantic
http://www.theatlantic.com/health/archive/2013/05/how-drug-companies-keep-medicine-out-of-reach/275853/?ReutersFor almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating illnesses. The class of maladies is known as neglected diseases, and they almost exclusively affect those in the developing world. The same idea, if realized, might also be used in more affluent nations to goad the pharmaceutical industry into producing critical innovations that the free market has yet to produce - things like new antibiotics, which are likely to be used ...
Source: PharmaGossip - May 15, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Drug donations are great, but should Big Pharma be setting the agenda?
Monday 29 April 2013 12.01 BST
Critics fear that giving out free medicines allows pharmaceutical companies to decide which diseases are treated
Vaccine donations might end after a period of time, leaving governments to pick up the bill. Photograph: Chris Hondros/Getty Images
Adam Robert Green for African Arguments, part of the Guardian Africa Network
In the early 2000s, pharmaceutical companies were high on activists' hit lists, prompted by Big Pharma's ill-advised attempt to sue the South African government for patent infringement on HIV drugs; an attempt to deal with the country's epidemic by allowing cheaper, generi...
Source: PharmaGossip - April 30, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
PhRMA Report: Over 5400 Medicines in Development and 70% are First in Class
According to report released by PhRMA, companies have more than 5,400 medicines in development globally, and more than 70% of therapies in the pipeline are potentially first-in-class and could offer patients new treatment options, and a notable number of potential therapies target diseases with limited treatment options such as ALS and rare diseases. A breakdown of their report offers insight into the various medicines in development for different diseases and populations.
Older Americans
America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditi...
Source: Policy and Medicine - April 24, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
